Clinical Trials
27 trialsNCT05631795 2026-04-07
ALPINIST
Novartis
Phase 4 Completed
NCT05822817 2025-06-08
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
Peking Union Medical College Hospital
Phase 4 Completed
NCT03289741 2025-05-09
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Memorial Sloan Kettering Cancer Center
Phase 4 Completed
NCT02842749 2025-02-10
Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China
Novartis
Phase 4 Completed
NCT04524442 2025-01-24
Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
Advanced Accelerator Applications
Phase 4 Completed
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT01379898 2024-09-19
PRESCRIPT
University Medical Center Groningen
Phase 4 Completed
NCT06576336 2024-08-28
3DAdrenal
University of Palermo
Phase 4 Completed
NCT02351700 2021-10-21
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
St. Joseph's Hospital and Medical Center, Phoenix
Phase 4 Completed
NCT01789281 2021-06-11
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Novartis
Phase 4 Completed
NCT00681187 2019-11-22
SAPHE
Ipsen
Phase 4 Completed
NCT01525550 2019-07-30
A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
Pfizer
Phase 4 Completed
NCT02075606 2019-06-07
CALM-NET
Ipsen
Phase 4 Completed
NCT01595009 2018-11-29
An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)
Novartis
Phase 4 Completed
NCT00376064 2017-03-06
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
Phase 4 Completed
NCT01371643 2016-08-29
Surgical Debulking of Pituitary Adenomas
NYU Langone Health
Phase 4 Completed
NCT01317615 2016-03-30
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Novartis
Phase 4 Completed
NCT01554735 2015-07-29
Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men
Changi General Hospital
Phase 4 Completed
NCT01554865 2015-07-29
Effects of Diet-induced Weight Loss in Obese Men
Changi General Hospital
Phase 4 Completed
NCT01642576 2015-07-29
Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men
Changi General Hospital
Phase 4 Completed
NCT01437696 2014-09-05
How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months?
McGill University
Phase 4 Completed
NCT01853566 2014-09-03
Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old
Universidade Federal do Rio de Janeiro
Phase 4 Completed
NCT01959711 2013-10-10
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy
Jagiellonian University
Phase 4 Completed
NCT00764114 2013-05-06
DTS
Assistance Publique - Hôpitaux de Paris
Phase 4 Completed
NCT00204373 2012-10-30
Treatment of Zollinger-Ellison Syndrome With Prevacid
University of Alabama at Birmingham
Phase 4 Completed
NCT00493987 2010-05-13
5aR
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 4 Completed
NCT00461149 2007-04-17
HDacro
Federico II University
Phase 4 Completed